Every morning, we provide a selection of analysts’ recommendations. The list includes companies that have experienced a change in opinion, a revision in the price target, or new coverage.

Abbvie: Cantor Fitzgerald initiates an overweight recommendation with a target price of USD 200.

Applied Materials: Citigroup maintains its buy recommendation and raises the target price from USD 211 to USD 250.

Corpay: Wolfe Research downgrades to underperform from peerperform with a target price of USD 295.

Darden Restaurants: BTIG upgrades to buy from neutral with a target price of USD 175.

Deere & Company: Oppenheimer maintains its outperform recommendation and raises the target price from USD 456 to USD 465.

Delta Air Lines: Wolfe Research maintains its outperform recommendation and raises the target price from USD 60 to USD 66.

Dr Horton: Citigroup maintains its buy recommendation with a price target reduced from USD 191 to USD 181.

Epam Systems: Wolfe Research downgrades to peerperform from outperform.

Grab Holdings Limited: Autonomous Research maintains its underperform recommendation and reduces the target price from USD 4 to USD 3.80.

Intercontinental Exchange: Redburn Atlantic maintains its buy recommendation and raises the target price from USD 166 to USD 167.

Netflix: Rosenblatt Securities Inc. maintains a neutral recommendation with a price target raised from USD 540 to USD 554.

Pultegroup: Citigroup remains neutral recommendation with a price target raised from USD 127 to USD 129.

Ross Stores: Gordon Haskett maintains its buy recommendation and raises the target price from USD 154 to USD 165.

Take-Two Interactive: ROTH MKM maintains its buy recommendation and reduces the target price from USD 185 to USD 180.

United Airlines Holdings: Wolfe Research upgrades to outperform from peerperform with a target price of USD 76.

Walmart: TD Cowen maintains its buy recommendation and raises the target price from USD 68 to USD 75.

Stay tuned for more updates throughout the session as we track these and other significant changes in analysts’ recommendations.